A new trial found that a progesterone-mimicking drug used to manage hot flashes and other symptoms may have anticancer ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen treatment for women with breast cancer, a new Cambridge-led trial has found.

Progesterone Receptor Positive (PR+) breast cancer is a distinct biological subtype of hormone receptor positive breast cancer. This type of cancer grows in response to progesterone, a hormone that is ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen treatment for women with breast cancer, a new Cambridge-led trial has found. A low ...

By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 6, 2026 (HealthDay News) — A drug that mimics the female hormone progesterone might help women fight hormone-fueled breast cancer.

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy.

Menopausal hormone replacement therapy, or MHT, was once routinely used to relieve symptoms of menopause and protect against ...

Your doctor may prescribe hormone therapy if you have late-stage cancer and sometimes if you have working ovaries and want to get pregnant. Photo Credit: iStock/Getty Images Hormone therapy for ...